Literature DB >> 24408978

Role of the M3 muscarinic acetylcholine receptor subtype in murine ophthalmic arteries after endothelial removal.

Adrian Gericke1, Andreas Steege, Caroline Manicam, Tobias Böhmer, Jürgen Wess, Norbert Pfeiffer.   

Abstract

PURPOSE: We tested the hypothesis that the M3 muscarinic acetylcholine receptor subtype mediates cholinergic responses in murine ophthalmic arteries after endothelial removal.
METHODS: Muscarinic receptor gene expression was determined in ophthalmic arteries with intact and with removed endothelium using real-time PCR. To examine the role of the M3 receptor in mediating vascular responses, ophthalmic arteries from M3 receptor-deficient mice (M3R(-/-)) and respective wild-type controls were studied in vitro. Functional studies were performed in nonpreconstricted arteries with either intact or removed endothelium using video microscopy.
RESULTS: In endothelium-intact ophthalmic arteries, mRNA for all five muscarinic receptor subtypes was detected, but M3 receptor mRNA was most abundant. In endothelium-removed ophthalmic arteries, M1, M2, and M3 receptors displayed similar mRNA expression levels, which were higher than those for M4 and M5 receptors. In functional studies, acetylcholine evoked vasoconstriction in endothelium-removed arteries from wild-type mice that was virtually abolished after incubation with the muscarinic receptor blocker atropine, indicative of the involvement of muscarinic receptors. In concentration-response experiments, acetylcholine and carbachol concentration-dependently constricted endothelium-removed ophthalmic arteries from wild-type mice, but produced only negligible responses in arteries from M3R(-/-) mice. In contrast, acetylcholine concentration-dependently dilated ophthalmic arteries with intact endothelium from wild-type mice, but not from M3R(-/-) mice. Responses to the nitric oxide donor nitroprusside and to KCl did not differ between ophthalmic arteries from wild-type and M3R(-/-) mice, neither in endothelium-intact nor in endothelium-removed arteries.
CONCLUSIONS: These findings provide evidence that in murine ophthalmic arteries the muscarinic M3 receptor subtype mediates cholinergic endothelium-dependent vasodilation and endothelium-independent vasoconstriction.

Entities:  

Keywords:  acetylcholine; mice; muscarinic receptors; ophthalmic arteries; vasoconstriction

Mesh:

Substances:

Year:  2014        PMID: 24408978      PMCID: PMC3908684          DOI: 10.1167/iovs.13-13549

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  48 in total

1.  Influence of nitric oxide synthase inhibition and endothelin-1 receptor blockade on acetylcholine-induced coronary artery contraction in vitro in dilated and ischemic cardiomyopathies.

Authors:  E Thorin
Journal:  J Cardiovasc Pharmacol       Date:  2001-07       Impact factor: 3.105

2.  Lack of specificity of commercially available antisera: better specifications needed.

Authors:  Wisuit Pradidarcheep; Wil T Labruyère; Noshir F Dabhoiwala; Wouter H Lamers
Journal:  J Histochem Cytochem       Date:  2008-09-15       Impact factor: 2.479

3.  Functional role of α1-adrenoceptor subtypes in murine ophthalmic arteries.

Authors:  Adrian Gericke; Marcin L Kordasz; Andreas Steege; Atsushi Sanbe; Evgeny Goloborodko; Jan M Vetter; Andreas Patzak; Norbert Pfeiffer
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-01       Impact factor: 4.799

4.  Identification of the muscarinic acetylcholine receptor subtype mediating cholinergic vasodilation in murine retinal arterioles.

Authors:  Adrian Gericke; Jan J Sniatecki; Evgeny Goloborodko; Andreas Steege; Olga Zavaritskaya; Jan M Vetter; Franz H Grus; Andreas Patzak; Jürgen Wess; Norbert Pfeiffer
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-27       Impact factor: 4.799

5.  Prediction of functionally selective allosteric interactions at an M3 muscarinic acetylcholine receptor mutant using Saccharomyces cerevisiae.

Authors:  Gregory D Stewart; Patrick M Sexton; Arthur Christopoulos
Journal:  Mol Pharmacol       Date:  2010-05-13       Impact factor: 4.436

6.  Detection of novel functional selectivity at M3 muscarinic acetylcholine receptors using a Saccharomyces cerevisiae platform.

Authors:  Gregory D Stewart; Patrick M Sexton; Arthur Christopoulos
Journal:  ACS Chem Biol       Date:  2010-04-16       Impact factor: 5.100

7.  Role of M1, M3, and M5 muscarinic acetylcholine receptors in cholinergic dilation of small arteries studied with gene-targeted mice.

Authors:  Adrian Gericke; Jan J Sniatecki; Veronique G A Mayer; Evgeny Goloborodko; Andreas Patzak; Jürgen Wess; Norbert Pfeiffer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-02-18       Impact factor: 4.733

8.  Cholinergic responses of ophthalmic arteries in M3 and M5 muscarinic acetylcholine receptor knockout mice.

Authors:  Adrian Gericke; Veronique G A Mayer; Andreas Steege; Andreas Patzak; Ulrike Neumann; Franz H Grus; Stephanie C Joachim; Lars Choritz; Jürgen Wess; Norbert Pfeiffer
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-04-30       Impact factor: 4.799

Review 9.  Endothelial dysfunction in glaucoma.

Authors:  Hemma Resch; Gerhard Garhofer; Gabriele Fuchsjäger-Mayrl; Anton Hommer; Leopold Schmetterer
Journal:  Acta Ophthalmol       Date:  2008-05-27       Impact factor: 3.761

10.  Suitability of muscarinic acetylcholine receptor antibodies for immunohistochemistry evaluated on tissue sections of receptor gene-deficient mice.

Authors:  Gitte Jositsch; Tamara Papadakis; Rainer V Haberberger; Miriam Wolff; Jürgen Wess; Wolfgang Kummer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-10-31       Impact factor: 3.000

View more
  8 in total

1.  Endothelium-specific amyloid precursor protein deficiency causes endothelial dysfunction in cerebral arteries.

Authors:  Livius V d'Uscio; Tongrong He; Anantha V Santhanam; Zvonimir S Katusic
Journal:  J Cereb Blood Flow Metab       Date:  2017-09-29       Impact factor: 6.200

Review 2.  The role of H2S bioavailability in endothelial dysfunction.

Authors:  Rui Wang; Csaba Szabo; Fumito Ichinose; Asif Ahmed; Matthew Whiteman; Andreas Papapetropoulos
Journal:  Trends Pharmacol Sci       Date:  2015-06-09       Impact factor: 14.819

3.  Ablation of lysozyme M-positive cells prevents aircraft noise-induced vascular damage without improving cerebral side effects.

Authors:  Thomas Münzel; Sebastian Steven; Katie Frenis; Johanna Helmstädter; Yue Ruan; Eva Schramm; Sanela Kalinovic; Swenja Kröller-Schön; Maria Teresa Bayo Jimenez; Omar Hahad; Matthias Oelze; Subao Jiang; Philip Wenzel; Clemens J Sommer; Katrin B M Frauenknecht; Ari Waisman; Adrian Gericke; Andreas Daiber
Journal:  Basic Res Cardiol       Date:  2021-04-30       Impact factor: 17.165

4.  The cholinergic system modulates negative BOLD responses in the prefrontal cortex once electrical perforant pathway stimulation triggers neuronal afterdischarges in the hippocampus.

Authors:  Alberto Arboit; Karla Krautwald; Frank Angenstein
Journal:  J Cereb Blood Flow Metab       Date:  2021-09-30       Impact factor: 6.200

Review 5.  Muscarinic Acetylcholine Receptors in the Retina-Therapeutic Implications.

Authors:  Yue Ruan; Andreas Patzak; Norbert Pfeiffer; Adrian Gericke
Journal:  Int J Mol Sci       Date:  2021-05-08       Impact factor: 5.923

6.  The Gatekeepers in the Mouse Ophthalmic Artery: Endothelium-Dependent Mechanisms of Cholinergic Vasodilation.

Authors:  Caroline Manicam; Julia Staubitz; Christoph Brochhausen; Franz H Grus; Norbert Pfeiffer; Adrian Gericke
Journal:  Sci Rep       Date:  2016-02-02       Impact factor: 4.379

7.  Compensatory Vasodilator Mechanisms in the Ophthalmic Artery of Endothelial Nitric Oxide Synthase Gene Knockout Mice.

Authors:  Caroline Manicam; Natalja Ginter; Huige Li; Ning Xia; Evgeny Goloborodko; Jenia Kouchek Zadeh; Aytan Musayeva; Norbert Pfeiffer; Adrian Gericke
Journal:  Sci Rep       Date:  2017-08-02       Impact factor: 4.379

8.  Optogenetic Stimulation of Cholinergic Amacrine Cells Improves Capillary Blood Flow in Diabetic Retinopathy.

Authors:  Elena Ivanova; Paola Bianchimano; Carlo Corona; Cyril G Eleftheriou; Botir T Sagdullaev
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-08-03       Impact factor: 4.799

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.